We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$20B
AUM Growth
+$1.88B
Cap. Flow
+$1.7B
Cap. Flow %
8.49%
Top 10 Hldgs %
14%
Holding
1,901
New
565
Increased
401
Reduced
415
Closed
510

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Consumer Discretionary 15.25%
3 Technology 14.69%
4 Industrials 11.95%
5 Financials 11.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
26
Equifax
EFX
$21.4B
$128M 0.64%
1,085,370
+604,624
+126% +$72.6M
MU icon
27
Micron Technology
MU
$991B
$125M 0.63%
2,403,802
-209,565
-8% -$10M
PM icon
28
Philip Morris
PM
$295B
$125M 0.63%
1,260,572
+23,245
+2% +$2.42M
XL
29
DELISTED
XL Group Ltd.
XL
$125M 0.63%
2,260,982
+1,886,108
+503% +$82.8M
CSL icon
30
Carlisle Companies
CSL
$15.4B
$123M 0.62%
1,182,582
+21,694
+2% +$2.38M
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
$121M 0.61%
1,084,891
+982,419
+959% +$117M
DHR icon
32
Danaher
DHR
$144B
$119M 0.6%
1,374,350
-834,875
-38% -$73M
EA
33
DELISTED
Electronic Arts
EA
$117M 0.59%
965,967
+254,397
+36% +$30.8M
GPN icon
34
Global Payments
GPN
$22.8B
$116M 0.58%
1,043,547
+513,393
+97% +$56.7M
ROST icon
35
Ross Stores
ROST
$81.9B
$114M 0.57%
1,459,826
+344,725
+31% +$27.4M
CTAS icon
36
Cintas
CTAS
$81.3B
$109M 0.54%
2,547,908
+1,101,440
+76% +$45.7M
USFD icon
37
US Foods
USFD
$24B
$108M 0.54%
3,304,772
+394,292
+14% +$12.9M
VRTX icon
38
Vertex Pharmaceuticals
VRTX
$126B
$108M 0.54%
660,268
-162,620
-20% -$26.6M
MRVL icon
39
Marvell Technology
MRVL
$196B
$107M 0.54%
5,116,649
-1,300,806
-20% -$29.8M
SAGE
40
DELISTED
Sage Therapeutics
SAGE
$102M 0.51%
632,100
-4,917
-0.8% -$835K
ATO icon
41
Atmos Energy
ATO
$28.8B
$100M 0.5%
1,191,618
+603,533
+103% +$49.1M
KEYS icon
42
Keysight
KEYS
$58.3B
$99.8M 0.5%
1,905,750
-601,751
-24% -$28.7M
WFC icon
43
Wells Fargo
WFC
$264B
$99.4M 0.5%
+1,896,423
New +$113M
VISN
44
Vistance Networks Inc
VISN
$2.52B
$98.3M 0.49%
2,459,566
+673,219
+38% +$26.3M
DG icon
45
Dollar General
DG
$27.9B
$97.9M 0.49%
1,046,055
+941,169
+897% +$90.4M
WMB icon
46
Williams Companies
WMB
$86.1B
$95.6M 0.48%
3,845,189
+3,122,910
+432% +$92.1M
HII icon
47
Huntington Ingalls Industries
HII
$12.8B
$94.7M 0.47%
367,555
+343,249
+1,412% +$85.1M
BMY icon
48
Bristol-Myers Squibb
BMY
$132B
$93.2M 0.47%
1,473,854
+1,252,722
+567% +$80.6M
BERY
49
DELISTED
Berry Global Group, Inc.
BERY
$92.7M 0.46%
1,841,913
+206,372
+13% +$10.7M
NOW icon
50
ServiceNow
NOW
$129B
$91.1M 0.46%
2,752,265
-1,225,190
-31% -$37.8M

Similar funds

Marshall Wace North America's Q1 2018 Portfolio in Review

As of Q1 2018, Marshall Wace North America held 1,901 positions worth $20B, up 10% from $18.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.7B of net new capital in Q1 2018, opening 565 new positions and adding to 401 existing holdings. Its largest new stake was Citigroup: 2,429,984 shares worth $164M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $285M trimmed.

  • Marshall Wace North America's largest Q1 2018 buy was Citigroup: 2,429,984 shares worth $164M.
  • Marshall Wace North America added most to Microsoft in Q1 2018, an estimated $328M increase.
  • Marshall Wace North America's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $285M.
  • Marshall Wace North America fully exited Manulife Financial in Q1 2018, selling an estimated $83.9M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $20B portfolio in Q1 2018.
  • Marshall Wace North America opened 565 new positions and closed 510 in Q1 2018.
  • Marshall Wace North America's portfolio value rose 10% quarter-over-quarter to $20B.

Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.